InsiderDirector

Tal Zvi Zaks Insider Trading Activity

Every SEC Form 4 transaction reported by Tal Zvi Zaks, sourced directly from SEC EDGAR and updated as new filings are accepted.

Latest filing:

Compiled automatically from SEC EDGAR Form 4 filings and refreshed daily. Figures count purchases (code P) and sales (code S) only — not grants, option exercises, or gifts. How this page is built. Not investment advice.

Quick Answer

Is Tal Zvi Zaks buying or selling?

Tal Zvi Zaks reported 0 open-market buys ($0) and 74 sells ($124.2M) across 74 Form 4 filings at 2 companies — a net selling position of $124.2M.

Source: SEC EDGAR Form 4

What stands out

  • Tal Zvi Zaks has reported Form 4 transactions at 2 companies; the most active, Moderna, Inc. (MRNA), accounts for 73 of 74 filings (99%).
  • The most recent Form 4 was accepted on Aug 10, 2026 (2 months ago).
  • In the last 12 months: no open-market purchases and 1 sale ($592.71).
  • The largest open-market sale in the last 12 months was $592.71 of TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) on Aug 10, 2026. SEC ↗

Key Statistics (as of Aug 10, 2026)

Total Form 4 filings
74
SEC EDGAR
Companies
2
Buys (0)
$0
Sells (74)
$124.2M

Insider sentiment

Net selling

Net insider flow of $124.2M in net selling, filed between Dec 17, 2019 – Aug 10, 2026.

Companies Tal Zvi Zaks files for

#CompanyForm 4 filings
1MRNAModerna, Inc.73
2TEVATEVA PHARMACEUTICAL INDUSTRIES LTD1

Recent Tal Zvi Zaks transactions

DateTickerRoleTypeSharesValueFiling
Aug 10, 2026TEVADirectorSale17$592.71SEC ↗
Jul 2, 2021MRNAChief Medical OfficerSale5.0K$1.2MSEC ↗
Jun 25, 2021MRNAChief Medical OfficerSale5.0K$1.1MSEC ↗
Jun 21, 2021MRNAChief Medical OfficerSale5.0K$1.0MSEC ↗
Jun 11, 2021MRNAChief Medical OfficerSale5.0K$1.1MSEC ↗
Jun 3, 2021MRNAChief Medical OfficerSale5.0K$919.5KSEC ↗
May 27, 2021MRNAChief Medical OfficerSale5.0K$843.5KSEC ↗
May 20, 2021MRNAChief Medical OfficerSale5.0K$778.7KSEC ↗
May 13, 2021MRNAChief Medical OfficerSale5.0K$770.5KSEC ↗
May 11, 2021MRNAChief Medical OfficerSale3.7K$581.6KSEC ↗
May 4, 2021MRNAChief Medical OfficerSale5.0K$932.3KSEC ↗
Apr 27, 2021MRNAChief Medical OfficerSale5.0K$879.5KSEC ↗
Apr 20, 2021MRNAChief Medical OfficerSale5.0K$815.2KSEC ↗
Apr 13, 2021MRNAChief Medical OfficerSale5.0K$694.8KSEC ↗
Apr 6, 2021MRNAChief Medical OfficerSale5.0K$648.5KSEC ↗
Mar 23, 2021MRNAChief Medical OfficerSale1.2K$173.6KSEC ↗
Mar 16, 2021MRNAChief Medical OfficerSale10.0K$1.4MSEC ↗
Mar 10, 2021MRNAChief Medical OfficerSale16.5K$2.1MSEC ↗
Mar 2, 2021MRNAChief Medical OfficerSale10.0K$1.5MSEC ↗
Feb 24, 2021MRNAChief Medical OfficerSale5.0K$824.2KSEC ↗
Feb 9, 2021MRNAChief Medical OfficerSale3.7K$677.3KSEC ↗
Feb 2, 2021MRNAChief Medical OfficerSale5.0K$811.7KSEC ↗
Jan 26, 2021MRNAChief Medical OfficerSale5.0K$715.6KSEC ↗
Jan 20, 2021MRNAChief Medical OfficerSale5.0K$619.4KSEC ↗
Jan 12, 2021MRNAChief Medical OfficerSale5.0K$585.6KSEC ↗

Showing the 25 most recent filings of 74. Screen every filing.

Tal Zvi Zaks insider trading FAQ

Is Tal Zvi Zaks buying or selling?

Across 74 SEC Form 4 filings, Tal Zvi Zaks reported 0 open-market purchases totaling $0 and 74 sales totaling $124.2M — a net selling position of $124.2M.

Which companies does Tal Zvi Zaks file Form 4s for?

Tal Zvi Zaks has reported insider transactions at 2 companies, most often Moderna, Inc. (MRNA), TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA).

How far back does Tal Zvi Zaks's filing history go?

Trabud holds Tal Zvi Zaks's SEC Form 4 filings from Dec 17, 2019 – Aug 10, 2026, sourced directly from SEC EDGAR.

Where does Trabud get Tal Zvi Zaks's insider trading data?

Directly from SEC EDGAR Form 4 filings. Every transaction on this page is a real filing accepted by the SEC, updated as new filings arrive.

Related Content

Track Tal Zvi Zaks and every other insider

Screen all SEC Form 4 filings by insider, company, transaction value, and role — or ask Trabud's AI agent in plain English.

Open the screener